Theravance Biopharma, Inc. — filings

CIK 1583107

Aggregates

computed from the filings below
Documents on record
2
Form types used
2
Filed in last 12 months
2
Median interval
14 d
between consecutive filings
Most used form
10-Q
1 filings
Most recent filing
2026-08-25
Filed on a Friday
0
of the filings shown
Earliest shown
2026-08-11

By form type

FormFilingsMost recent
10-Q12026-08-11
8-K12026-08-25

Documents

2 most recent shown
FiledFormAccessionSource
2026-08-258-K0001104659-26-100860document
2026-08-1110-Q0001104659-26-093773document

Source: U.S. Securities and Exchange Commission, EDGAR